OnKure Therapeutics, Inc. (NASDAQ:OKUR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Edward Mathers Other companies: NeueHealth Inc (Director · Since at least Oct 2, 2025); MBX Biosciences, Inc. (Director · Since at least Sep 12, 2024); Senti Biosciences Holdings, Inc. (Director · Since at least Jun 8, 2022); Trevi Therapeutics, Inc. (Director · Since at least May 7, 2019); Rhythm Pharmaceuticals, Inc. (Director · Since at least Oct 4, 2017); Inozyme Pharma Inc (Director · Jul 23, 2020 – Jun 18, 2024 · Past); Akouos Inc (Director · Jun 25, 2020 – Dec 1, 2022 · Past); Mirum Pharmaceuticals, Inc. (Director · Jul 17, 2019 – Jun 2, 2022 · Past); Ra Pharmaceuticals Inc (Director · Jun 28, 2018 – Apr 2, 2020 · Past); Synlogic Inc (Director · Dec 29, 2017 – Jun 22, 2023 · Past) | Director · Since at least Apr 8, 2021 |
| Michael Grey Other companies: Spruce Biosciences, Inc. (Executive Chairman, Director · Since at least Oct 8, 2020); Mirum Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2019); Horizon Pharma PLC (Director · Sep 29, 2011 – May 3, 2018 · Past); BioMarin Pharmaceutical Inc. (Director · Dec 14, 2006 – Mar 5, 2021 · Past); Achillion Pharmaceuticals Inc (Director · Oct 25, 2006 – Dec 18, 2009 · Past); Idm Pharma Inc (Director · Jun 14, 2006 – Dec 11, 2008 · Past); SGX Pharmaceuticals Inc (President & CEO, Director · Jan 31, 2006 – Aug 20, 2008 · Past) | Director · Since at least Apr 8, 2021 |
| Isaac Manke Other companies: Rainier Acquisition Corporation (Director · Since at least Aug 26, 2026); Addex Therapeutics Ltd (Director · Since at least Mar 18, 2026); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Chardan Healthcare Acquisition 2 Corp (Director · Apr 23, 2020 – Apr 23, 2020 · Past) | Director · Since at least Oct 4, 2024 |
| Ashley Hall Other companies: Structure Therapeutics, Inc. (Chief Development Officer · Since at least Sep 18, 2024); Esperion Therapeutics, Inc. (Chief Development Officer · Feb 26, 2020 – Jan 28, 2021 · Past) | Chief Development Officer · Oct 11, 2020 – Aug 28, 2023 · Past |
| Bali Muralidhar Other companies: Spruce Biosciences, Inc. (Director · Since at least Oct 8, 2020); Exicure, Inc. (Director · Jun 2, 2021 – Jun 13, 2022 · Past) | Director · Apr 8, 2021 – Jun 6, 2023 · Past |
| Wendy S Johnson Other companies: Exagen Inc. (Director · Oct 1, 2020 – Jun 9, 2023 · Past); Armata Pharmaceuticals, Inc. (Director · Sep 8, 2015 – Sep 7, 2017 · Past) | Chief Development Officer · Apr 8, 2021 – Jul 14, 2021 · Past |
| Jason Leverone Other companies: Viridian Therapeutics, Inc. (Chief Financial Officer · Jan 18, 2021 – Jan 18, 2021 · Past) | Chief Financial Officer · Since at least Oct 4, 2024 |
| Johan Kordel Other companies: Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Feb 4, 2014 · Past) | Director · Apr 8, 2021 – Apr 8, 2021 · Past |
| Samuel Agresta Other companies: Foghorn Therapeutics Inc. (Chief Medical Officer · Oct 22, 2020 – Sep 11, 2023 · Past) | Chief Medical Officer · Since at least Oct 4, 2024 |
| Stacey Denenberg Seltzer Other companies: Aimmune Therapeutics Inc (Director · Aug 5, 2015 – Oct 10, 2020 · Past) | Director · Apr 8, 2021 – Jun 6, 2023 · Past |
| Valerie Jansen Other companies: Elevation Oncology Inc (CHIEF MEDICAL OFFICER · Jan 6, 2023 – Feb 15, 2025 · Past) | Director · Since at least Oct 4, 2024 |
| Aaron Goodwin | Vice President of Pharmaceutical Sciences and Supply Chain · Since at least Nov 4, 2026 |
| Andrew Phillips | Director · Since at least Mar 27, 2026 |
| David Mareska | Vice President, Discovery Chemistry · Since at least Nov 4, 2026 |
| Dylan Hartley | Chief Scientific Officer · Since at least Oct 4, 2024 |
| Gregory J Flesher | President and CEO, Director · Apr 8, 2021 – Dec 9, 2022 · Past |
| James Blake | Senior Vice President of Computational Drug Discovery · Since at least Nov 4, 2026 |
| Jennifer Lam | VP of Finance & Administration · Mar 31, 2022 – Dec 9, 2022 · Past |
| Jim Wong | Vice President, Biological Sciences · Since at least Nov 4, 2026 |
| Kevin S. Litwiler | Senior Vice President of DMPK and Clinical Pharmacology · Since at least Nov 4, 2026 |
| Liam Ratcliffe | Director · Since at least Mar 27, 2026 |
| Mark L. Boys | Senior Vice President of Discovery Chemistry · Since at least Nov 4, 2026 |
| Nicholas A. Saccomano | President and CEO, Director · Since at least Jun 22, 2026 |
| Qian Zhao | Vice President and Distinguished Fellow · Since at least Nov 4, 2026 |
| R. Michael Carruthers | Director · Since at least Nov 5, 2026 |
| Robbie Alton | Senior Vice President of Clinical Operations · Since at least Nov 4, 2026 |
| Rogan Nunn | General Counsel and Secretary · Since at least Nov 4, 2026 |